|
Original Manuscripts
|
|
Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD)
|
1861
|
|
J Taguchi, Y Miyazaki, S Yoshida, T Fukushima, Y Moriuchi, I Jinnai, T Matsuo, K Kuriyama & M Tomonaga
|
| Abstract Full Article PDF
|
 |
|
BP1, a new homeobox gene, is frequently expressed in acute leukemias
|
1867
|
|
SB Haga, S Fu, JE Karp, DD Ross, DM Williams, WD Hankins, F Behm, FW Ruscetti, M Chang, BD Smith, D Becton, SC Raimondi & PE Berg
|
| Abstract Full Article PDF
|
| |
|
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice
|
1876
|
|
D Louz, M van den Broek, S Verbakel, Y Vankan, K van Lom, M Joosten, D Meijer, B Löwenberg & R Delwel
|
| Abstract Full Article PDF
|
| |
|
MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study
|
1885
|
|
G Cuthbert, K Thompson, S McCullough, A Watmore, H Dickinson, N Telford, F Mugneret, C Harrison, M Griffiths & N Bown
|
| Abstract Full Article PDF
|
| |
|
Cytoplasmic and nuclear localization of the 130 and 160 kDa Bcr proteins
|
1892
|
|
E Laurent, M Talpaz, M Wetzler & R Kurzrock
|
| Abstract Full Article PDF
|
| |
|
The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds
|
1898
|
|
C Caslini, A Serna Alarcòn, JL Hess, R Tanaka, KG Murti & A Biondi
|
| Abstract Full Article PDF
|
| |
|
Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2
|
1909
|
|
A Grolleau, J Wietzerbin & L Beretta
|
| Abstract Full Article PDF
|
| |
|
Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells
|
1915
|
|
T Ando, M Nishimura & Y Oka
|
| Abstract Full Article PDF
|
| |
|
Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells
|
1921
|
|
C Weinstein-Oppenheimer, LS Steelman, PA Algate, WL Blalock, C Burrows, PE Hoyle, JT Lee, PW Moye, JG Shelton, R Franklin & JA McCubrey
|
| Abstract Full Article PDF
|
| |
|
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group
|
1939
|
|
A Biondi, MG Valsecchi, T Seriu, E D'Aniello, MJ Willemse, K Fasching, A Pannunzio, H Gadner, M Schrappe, WA Kamps, CR Bartram, JJM van Dongen & ER Panzer-Grümayer
|
| Abstract Full Article PDF
|
| |
|
Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood
|
1944
|
|
N Kusadasi, PL van Soest, AE Mayen, JLM Koevoet & RE Ploemacher
|
| Abstract Full Article PDF
|
| |
|
A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation
|
1954
|
|
E Olavarria, M Hassan, A Eades, C Nilsson, A Timms, J Matthews, C Craddock, E Kanfer, J Apperley & J Goldman
|
| Abstract Full Article PDF
|
| |
|
De novo acute B cell leukemia/lymphoma with t(14;18)
|
1960
|
|
A Stamatoullas, G Buchonnet, S Lepretre, P Lenain, B Lenormand, C Duval, M-P Callat, P Gaulard, C Bastard & H Tilly
|
| Abstract Full Article PDF
|
| |
|
Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma
|
1967
|
|
J Kalla, S Stilgenbauer, C Schaffner, S Wolf, G Ott, A Greiner, A Rosenwald, H Döhner, HK Müller-Hermelink & P Lichter
|
| Abstract Full Article PDF
|
| |
|
Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance
|
1975
|
|
R Königsberg, J Ackermann, H Kaufmann, N Zojer, E Urbauer, E Krömer, U Jäger, H Gisslinger, S Schreiber, R Heinz, H Ludwig, H Huber & J Drach
|
| Abstract Full Article PDF
|
| |
|
Trends in mortality from leukemia in subsequent age groups
|
1980
|
|
F Levi, F Lucchini, E Negri, T Barbui & C La Vecchia
|
| Abstract Full Article PDF
|
| |
|
Identification of genes potentially involved in LMO2-induced leukemogenesis
|
1986
|
|
J Davenport, GAM Neale & R Goorha
|
| Abstract Full Article PDF
|
| |
|
|
Bio-Technical Methods Section (BTS)
|
Quantitation of DNA topoisomerase II and  in human leukaemia cells by immunoblotting
|
1997
|
|
K Padget, ADJ Pearson & CA Austin
|
| Abstract Full Article PDF
|
| |
|
Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes
|
2006
|
|
S Saußele, A Weißer, MC Müller, M Emig, P La Rosée, P Paschka, C Kuhn, A Willer, R Hehlmann & A Hochhaus
|
| Abstract Full Article PDF
|
| |
|
|
Correspondence
|
|
Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML
|
2011
|
|
M Dupont, E Jourdan & J Chiesa
|
| Full Article PDF
|
| |
|
Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO)
|
2013
|
|
H Iwata, M Kami, Y Kishi, Y Oki, Y Tanaka, K Takeuchi, I Yamazaki, R Suzuki, S Morinaga & Y Mutou
|
| Full Article PDF
|
| |
|
Loss of the TSG101 leucine zipper domain in aggressive non-Hodgkin's lymphomas
|
2014
|
|
M Ferrer, S Hernández, E Campo & PA Lazo
|
| Full Article PDF
|
| |
| |
| |
